Why the study?
Should glycaemic control be optimized before using lipid-lowering drugs in diabetic patients with gross hypertriglyceridaemia?
Should glycaemic control be optimized before using lipid-lowering drugs in diabetic patients with gross hypertriglyceridaemia?
Highlights the importance of optimizing glycemic control prior to initiating lipid-lowering therapy in diabetic patients with severe hypertriglyceridemia.
Answers are grounded in this paper and cite their sources.
May warrant glycemic optimization first in this setting; leaves open confirmation by prospective trials.
Mild hypertriglyceridaemia is common in diabetes, but patients with newly presenting or poorly controlled diabetes may have a quantitatively different syndrome of gross hypertriglyceridaemia, which should be treated by optimising glycaemic control before use of lipid lowering drugs.
No takes yet. Share an insight, caveat, or question.
W S A Smellie (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: